BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24414460)

  • 21. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
    Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
    Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
    Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique.
    Macciò A; Sanna E; Lavra F; Chiappe G; Petrillo M; Madeddu C
    BMC Surg; 2021 Oct; 21(1):380. PubMed ID: 34711237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
    Woelber L; Jung S; Eulenburg C; Mueller V; Schwarz J; Jaenicke F; Mahner S
    Eur J Surg Oncol; 2010 Jun; 36(6):583-8. PubMed ID: 20488646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.
    Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N
    Eur J Surg Oncol; 2014 Jul; 40(7):891-8. PubMed ID: 24378007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Laparoscopy and Laparotomy in Surgical Staging of Apparent Early Ovarian Cancer: 13-year Experience.
    Lu Q; Qu H; Liu C; Wang S; Zhang Z; Zhang Z
    Medicine (Baltimore); 2016 May; 95(20):e3655. PubMed ID: 27196468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. "The times they are a-changin"?
    Ceccaroni M; Roviglione G; Bruni F; Clarizia R; Ruffo G; Salgarello M; Peiretti M; Uccella S
    Surg Endosc; 2018 Apr; 32(4):2026-2037. PubMed ID: 29052073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series.
    Gallotta V; Giudice MT; Conte C; Sarandeses AV; D'Indinosante M; Federico A; Tortorella L; Carbone MV; Gueli Alletti S; Vizzielli G; Costantini B; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2018 Oct; 44(10):1568-1572. PubMed ID: 30170883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery.
    Benedetti Panici P; Perniola G; Angioli R; Zullo MA; Manci N; Palaia I; Bellati F; Plotti F; Calcagno M; Basile S
    Int J Gynecol Cancer; 2007; 17(6):1245-51. PubMed ID: 17425680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopy staging of early ovarian cancer: our experience and review of the literature.
    Ghezzi F; Cromi A; Siesto G; Serati M; Zaffaroni E; Bolis P
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S7-S13. PubMed ID: 19955918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extraperitoneal laparoscopic para-aortic lymphadenectomy as a diagnostic procedure for lymph node recurrence of gynaecological cancers.
    Sanjuán A; Illa M; Torné A; Román SM; Jurado M; Lejarcegui JA; Pahisa J
    Acta Obstet Gynecol Scand; 2007; 86(4):491-5. PubMed ID: 17486474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic Excision of a 5-cm Retroaortic Relapse of Ovarian Cancer.
    Uccella S; Zorzato PC; Forliti E; Gallina D; Lanzo G
    J Minim Invasive Gynecol; 2020; 27(5):1017-1018. PubMed ID: 31610317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.
    Nezhat FR; DeNoble SM; Liu CS; Cho JE; Brown DN; Chuang L; Gretz H; Saharia P
    JSLS; 2010; 14(2):155-68. PubMed ID: 20932362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
    Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
    Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.